Unique ID issued by UMIN | UMIN000026977 |
---|---|
Receipt number | R000030934 |
Scientific Title | Endovascular therapy using TruePathTM chronic total occlusion device, a multicenter prospective study |
Date of disclosure of the study information | 2017/05/01 |
Last modified on | 2022/10/17 22:28:10 |
Endovascular therapy using TruePathTM chronic total occlusion device, a multicenter prospective study
Endovascular therapy using TruePathTM chronic total occlusion device, a multicenter prospective study
Endovascular therapy using TruePathTM chronic total occlusion device, a multicenter prospective study
Endovascular therapy using TruePathTM chronic total occlusion device, a multicenter prospective study
Japan |
Infrainguinal symptomatic peripheral artery disease with chronic total occlusion
Cardiology | Vascular surgery |
Others
NO
The evaluate the safety and efficacy of using TruePathTM CTO device for infrainguinal symptomatic peripheral artery disease with chronic total occlusion.
Safety,Efficacy
Procedure success (TruePath CTO device cross the target occlusion through to the true distal lumen)
Complication
Proportion of true lumen using IVUS analysis
Procedure time, device using time, fluoroscopy time, dose
Improvement of Rutherford category
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1)Informed consent was done
2)Infrainguinal peripheral artery disease with chronic total occulusion(included in-stent occulusion)
3)Atherosclerotic peripheral artery disease (Rutherford category 2-5)
4)ABI value was less than 0.9 or if the value was more than 0.9, the ischemia of lower limb was confirmed by other modalities.
5)Meet the criteria of EVT
6)More than 20 years old
7)Agreement the clinical follow up.(after procedure, 6 months, 12 months)
1)Less than 20 years old
2)Pregnancy
3)Stenotc lesions
4)Common femoral artery lesion (If EVT are going to perform for Iliac lesions simultaneously, it allows the study).
5)Planed other clinical study
6)Planed surgical bypass, below/above the knee amputation within 30 days
7)Poor life expectancy
8)Difficulty of antiplatelet therapy, anticoagrant therapy
9)Severe dementia
150
1st name | Yusuke |
Middle name | |
Last name | Tomoi |
Kokura Memorial Hospital
Cardiology
802-8555
Kokura-kita-ku, Asano 3-2-1 Kitakyushu city
093-511-2000
mbxtg263@ybb.ne.jp
1st name | Yusuke |
Middle name | |
Last name | Tomoi |
Kokura Memorial Hospital
Cardiology
802-8555
Kokura-kita-ku, Asano 3-2-1 Kitakyushu city
093-511-2000
mbxtg263@ybb.ne.jp
Kokura Memorial Hospital, Cardiology
none
Self funding
Kokura Memrial Hospital
3-2-1 Asano, Kokurakita-ku Kitakyushu
093-511-2000
mbxtg263@ybb.ne.jp
NO
小倉記念病院
2017 | Year | 05 | Month | 01 | Day |
J Endovasc Ther. 2020 Feb;27(1):69-76.
Published
J Endovasc Ther. 2020 Feb;27(1):69-76.
143
Complete success was achieved in 82 (56.2%) lesions; any success (complete plus assisted) was documented in 117 (80.1%) lesions.
2022 | Year | 10 | Month | 17 | Day |
mean age 75 years 101 men
prospective observational study
Four (3%) perioperative device-related complications were observed.
Complete success
Completed
2017 | Year | 04 | Month | 14 | Day |
2017 | Year | 04 | Month | 13 | Day |
2017 | Year | 05 | Month | 01 | Day |
2019 | Year | 02 | Month | 28 | Day |
Lesion length (TASC-II)
Type of chronic total occlusion
Calcification
2017 | Year | 04 | Month | 13 | Day |
2022 | Year | 10 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030934
Research Plan | |
---|---|
Registered date | File name |
2020/10/15 | 2017.04.18_TRUMP_study.docx |
Research case data specifications | |
---|---|
Registered date | File name |
2020/10/15 | 2017.04.18_TRUMP_study.docx |
Research case data | |
---|---|
Registered date | File name |
2020/10/15 | 2017.04.18_TRUMP_study.docx |